A Randomized, Double-blinded, Parallel Group, Placebo-Controlled, Multi-Center Trial of Topical Wound Oxygen Therapy in the Treatment of Diabetic Lower Extremity Ulcers
Description:
The AOTI two2 therapy trial is a randomized, double-blinded, parallel group,
placebo-controlled, multi-center study intended to evaluate the efficacy of Topical Wound
Oxygen (two2) therapy in relation to placebo when added to standard of care in the treatment
of diabetic lower extremity ulcers.
Condition:
Diabetic Ulcer
Treatment:
Topical wound oxygen therapy
Start Date:
May 2007
Sponsor:
AOTI Ltd.
For More Information:
https://clinicaltrials.gov/show/NCT00871312